Laparoscopic Device Industry to Reach USD 20.5 Billion by 2034 at a 4.2% of CAGR, Amid Growing Demand for Minimally Invasive Surgery

Laparoscopic Device Market
Laparoscopic Device Industry

The global laparoscopic device market is set to grow steadily over the next decade, with its valuation expected to increase from USD 13.59 billion in 2024 to over USD 20.5 billion by 2034, reflecting a CAGR of 4.2% during the forecast period. Despite ongoing supply chain disruptions, companies in the sector are deploying innovative strategies to ensure consistent product availability and meet growing demand.

The rising prevalence of obesity across all age groups is one of the primary drivers of this market expansion. As obesity is linked to numerous health complications that require surgical intervention, the demand for laparoscopic devices is poised to grow. Minimally invasive procedures, including laparoscopy, are increasingly preferred by both patients and healthcare providers due to their reduced recovery times, smaller incisions, and lower risk of complications.

To mitigate the impact of supply chain challenges, leading manufacturers are adopting robust operational strategies, such as localized production and diversified supplier networks. These measures are not only enhancing supply chain resilience but also ensuring that healthcare facilities worldwide have uninterrupted access to advanced laparoscopic devices.

A Comprehensive Full Report – https://www.futuremarketinsights.com/reports/laparoscopic-devices-market

Key Takeaways:

  • Steady Growth: The laparoscopic device market is projected to grow from $13.59 billion in 2024 to $20.5 billion by 2034, at a CAGR of 4.2%.
  • Obesity as a Growth Driver: Rising obesity rates across all demographics are significantly boosting demand for laparoscopic procedures.
  • Minimally Invasive Preference: The growing preference for minimally invasive surgeries is reinforcing the importance of advanced laparoscopic technologies.
  • Supply Chain Resilience: Companies are adopting strategic measures to address supply chain disruptions and maintain consistent product availability.

The laparoscopic device market’s progression highlights the ongoing evolution of surgical technology, ensuring better outcomes and experiences for patients worldwide.

Growth Drivers

  1. Rising Obesity Rates: The global obesity epidemic, largely influenced by poor dietary habits and sedentary lifestyles, is a primary driver for the demand for laparoscopic procedures aimed at treating obesity-related health conditions.
  2. Minimally Invasive Surgery Demand: There is a growing preference for minimally invasive surgical techniques due to their benefits, including reduced recovery times and lower postoperative pain.
  3. Technological Advancements: Innovations in laparoscopic devices, such as improved imaging systems and enhanced surgical instruments, are facilitating the adoption of these technologies in various surgical procedures.

Supply Chain Strategies

Despite the positive outlook for the market, companies are facing supply chain disruptions that affect the availability of laparoscopic devices. To mitigate these challenges, industry participants are employing various strategies, including:

  • Diversifying Suppliers: Companies are seeking additional suppliers to ensure a steady flow of materials and components.
  • Improving Logistics: Rerouting logistics and optimizing transportation methods to reduce delays.
  • Strategic Partnerships: Forming alliances with other manufacturers or suppliers to enhance resilience against disruptions.

Key Highlights of the Laparoscopic Device Industry

  • Advantages over open surgeries, like smaller incisions, less discomfort after surgery, shorter hospital stays, and quicker recovery times, laparoscopic treatments have become the procedure of choice for many surgeries.
  • The need for laparoscopic surgeries is being driven by conditions like obesity, gastrointestinal issues, and different forms of cancer.
  • Governments and the private healthcare sector are investing in healthcare infrastructure and technologies, including laparoscopic equipment to enhance patient outcomes and lower healthcare costs related to lengthier hospital stays and post-operative problems.

Competitive Landscape

Innovative companies are disrupting traditional players by introducing novel technologies and approaches in the laparoscopic device market. Startups are ascending advancements in robotics, artificial intelligence, and miniaturization for developing cutting-edge laparoscopic devices offering improved precision, efficiency, and patient outcomes.

Startups hence focus on niche segments or specialize in specific aspects of laparoscopic surgery, like imaging systems, energy devices, or surgical robotics.

Key developments in the laparoscopic device industry

  • In February 2023, Asensus Surgical, Inc. announced a Memorandum of Understanding with KARL STORZ VentureONE Pte. Ltd., that focused on endoscopes and laparoscopic vision systems.
  • In January 2022, Seger Surgical Solutions developed the LAP IA 60 device for intracorporeal anastomosis. The device efficiently aligned, sealed, and stapled intracorporeal anastomosis openings, which offered a secure and rapid solution without the need for internal fixation.

Key Companies Profiled

  • Olympus Corporation
  • B. Braun Melsungen AG
  • Intuitive Surgical Inc.
  • Medtronic plc.
  • Stryker Corporation
  • Smith & Nephew Plc
  • CareFusion Corporation
  • Ethicon US, LLC
  • Tekno-Medical Optik Surgery GmbH
  • Richard Wolf GmbH
  • Endocontrol SA

Key Segments

By Product:

  • Direct Energy System Devices
  • Trocars/Access Device
  • Internal Closure Devices
  • Laparoscopes
  • Hand Access Instruments
  • Insufflation Devices
  • Robotic Assisted Surgical System

By Therapeutic Application:

  • Bariatric Surgery
  • Colorectal Surgery
  • General Surgery
  • Gynecological Surgery
  • Urological Surgery

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *